ADTRAN 10-Q: Material Weaknesses Persist, Cash Falls to $64.6M as Q3 Loss Narrows
ADTN is trading near its 52-week low of $4.03 (2.5% above the low) on elevated volume (2.2× avg).
Summary
ADTRAN's Q3 10-Q confirms the results already announced November 3 and discloses that its material weaknesses in internal controls remain unremediated, with cash down to $64.6 million from $95.7 million at year-end.
Key Events · Earnings and Guidance · ADTN
-
Material Weaknesses Still Unremediated
Management concluded disclosure controls and procedures were not effective as of September 30, 2026 because the material weaknesses tied to the prior restatements remain; remediation controls must operate effectively for a sufficient period before the weaknesses can be considered fixed.
-
Cash Drops to $64.6 Million
Cash and cash equivalents fell from $95.7 million at December 31, 2025 to $64.6 million; including $7.1 million of restricted cash the total was $71.7 million, of which $57.4 million sits in foreign subsidiaries.
-
Operating Cash Flow Down $73.4 Million
Nine-month operating cash flow was $14.1 million versus $87.5 million a year earlier, with accounts receivable up $29.9 million and inventory up $18.7 million absorbing cash.
-
Loss Narrows, Tax Rate Jumps
Nine-month net loss attributable to ADTRAN was $21.5 million versus $42.1 million; the effective tax rate rose to 56.6% of pre-tax loss in Q3 from 18.3% on a $124.5 million valuation allowance against $115.1 million of net deferred tax assets.
Analysis · ADTN · Manufacturing
The quarter's headline numbers were already out on November 3, but the full 10-Q adds two things that matter. First, management concluded disclosure controls were not effective as of September 30, 2026 because the previously disclosed material weaknesses in internal control over financial reporting are still not remediated — the same weaknesses that produced restatements of 2022-2024 financials. Second, liquidity is tightening: cash and equivalents dropped to $64.6 million from $95.7 million at year-end, and nine-month operating cash flow of $14.1 million is $73.4 million below last year. Against that, the loss narrowed (net loss attributable to ADTRAN of $21.5 million for nine months versus $42.1 million) and the $350 million J.P. Morgan facility leaves $261.7 million available, with the company stating it has adequate resources for at least twelve months. The stock sits near its 52-week low of $4.03, so any further control or liquidity setback lands on an already depressed valuation.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADTN was trading at $4.13 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $336.5M. The 52-week trading range was $4.03 to $19.98. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.